Comparative survival analysis of breast cancer microarray studies identifies important prognostic genetic pathways

[1] Deroo B(2006)Estrogen receptors and human disease Journal of Clinical Investigation 116 561-570

[2] Korach K(2002)Progesterone receptors- animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer Breast Cancer Res 4 182-3696

[3] Gao X(1994)The biology of erbB-2/neu/HER-2 and its role in cancer Biochimica et biophysica acta 1198 165-13555

[4] Nawaz Z(2007)Prognostic Significance of TGF Anticancer research 27 2613-2009

[5] Hynes N(2005)-1 and pSmad2/3 in Breast Cancer Patients with T1-2, N0 Tumours Statistics in medicine 24 3687-357

[6] Stern D(2005)Evaluating technologies for classification and prediction in medicine Epidemiology 16 598-3743

[7] Koumoundourou D(2007)Standardizing diagnostic markers to evaluate and compare their performance Clinical Cancer Research 13 3207-15550

[8] Kassimatis T(2002)Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Nucleic acids research 30 207-129

[9] Zolota V(2005)Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Proceedings of the National Academy of Sciences 102 13550-2275

[10] Tzorakoeleftherakis E(2005)An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Breast Cancer Research 7 R953-502

[1] Deroo B(2006)Estrogen receptors and human disease Journal of Clinical Investigation 116 561-570

[2] Korach K(2002)Progesterone receptors- animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer Breast Cancer Res 4 182-3696

[3] Gao X(1994)The biology of erbB-2/neu/HER-2 and its role in cancer Biochimica et biophysica acta 1198 165-13555

[4] Nawaz Z(2007)Prognostic Significance of TGF Anticancer research 27 2613-2009

[5] Hynes N(2005)-1 and pSmad2/3 in Breast Cancer Patients with T1-2, N0 Tumours Statistics in medicine 24 3687-357

[6] Stern D(2005)Evaluating technologies for classification and prediction in medicine Epidemiology 16 598-3743

[7] Koumoundourou D(2007)Standardizing diagnostic markers to evaluate and compare their performance Clinical Cancer Research 13 3207-15550

[8] Kassimatis T(2002)Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Nucleic acids research 30 207-129

[9] Zolota V(2005)Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Proceedings of the National Academy of Sciences 102 13550-2275

[10] Tzorakoeleftherakis E(2005)An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Breast Cancer Research 7 R953-502